BTIG analyst Vincent Caintic updated the firm's stance on American Express (NYSE:AXP) shares, raising the price target to ...

What damage might Monday's ongoing selloff do to the technical set-up for stocks? Well, in a note published on Sunday, BTIG chartist guru Jonathan Krinsky observed that Friday's action had already sug ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Intuitive Surgical (ISRG – Research Report), with a price ...

Ginkgo Bioworks Holdings Inc (DNA) stock saw a decline, ending the day at $12.82 which represents a decrease of $-0.36 or -2.73% from the prior close of $13.18. The stock opened at $13.32 and touched ...

BTIG raised the firm’s price target on Intuitive Surgical (ISRG) to $622 from $561 and keeps a Buy rating on the shares after ...

Tuesday, shares of Ideaya Biosciences (NASDAQ:IDYA), trading at $22.18 near its 52-week low of $22.10, drew attention as BTIG analysts maintained their Buy rating and $62.00 price target. According to ...

In terms of valuation, Akebia Therapeutics Inc’s market capitalization stands at $519.27 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s ...

BTIG Chief Market Technician Jonathan Krinsky thinks the market can “continue to make upside progress” into year-end and sees a new all-time high for the S&P 500 (SPX) above 6,100. However ...

BTIG lowered the firm’s price target on Evolent Health (EVH) to $20 from $29 but keeps a Buy rating on the shares. The firm notes it was disappointed by the company’s comments around higher ...

CAD to Participate in the BTIG at Snowbird:12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASHUA, N.H., Jan.

BTIG analyst Jake Fuller says that while Uber‘s (UBER) commentary on its U.S. rideshare business “felt constructive” at intra-quarter appearances, the firm’s receipt data was “more ...